Bistos Co., Ltd. (KOSDAQ:419540)
South Korea · Delayed Price · Currency is KRW 1,179.00
-63.00 (-5.07%)
At close: Jan 23, 2026
Bistos Revenue
Bistos had revenue of 4.31B KRW in the quarter ending September 30, 2025, with 34.31% growth. This brings the company's revenue in the last twelve months to 19.37B, down -1.30% year-over-year. In the year 2024, Bistos had annual revenue of 20.25B, down -4.93%.
Revenue (ttm)
19.37B
Revenue Growth
-1.30%
P/S Ratio
1.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.25B | -1.05B | -4.93% |
| Dec 31, 2023 | 21.30B | -2.66B | -11.09% |
| Dec 31, 2022 | 23.96B | 3.44B | 16.77% |
| Dec 31, 2021 | 20.52B | 2.50B | 13.87% |
| Dec 31, 2020 | 18.02B | 6.38B | 54.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 102.75B |
| DRGEM | 98.34B |
| JPI Healthcare | 52.79B |
| CU Medical Systems | 44.79B |
| Neofect | 20.50B |
| DHX Company | 16.38B |
| MEKICS CO., | 11.70B |
| NANOOMTECH | 6.51B |